No Data
No Data
Appili Therapeutics Announces Receipt of Final Court Order for Arrangement With Aditxt, Inc.
Aditxt | 10-Q: Q3 2024 Earnings Report
Evofem Biosciences 3Q Loss/Shr 2c >EVFM
Express News | Evofem Biosciences Announces Financial Results for the Third Quarter of 2024
Press Release: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024
Express News | Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
No Data
No Data